Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...

Drug Dosing: Geriatric Patients

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...

Pharmacodynamics in Geriatric Patients: Effects of Age

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The synthesis of 6'-N-acyl neamine-based amphiphiles: Synergistic activity against Pseudomonas aeruginosa via enhanced membrane permeability.

European journal of medicinal chemistry·2026

Same author

Systems-level multi-omics dissection of syndromic and idiopathic autism reveals distinct regulatory architectures, candidate molecular signatures, and potential therapeutic targets.

Computers in biology and medicine·2026

Same author

In silico identification and prioritization of potential drug targets in Wuchereria bancrofti: Profilin as a promising therapeutic candidate.

Computational biology and chemistry·2026

Same author

Mitochondrial rescue in Alzheimer's disease: Exploring marine-derived compounds for brain metabolism regulation.

International review of neurobiology·2026

Same author

Marine-derived polysaccharides and peptides as next-generation immunomodulators: Molecular mechanisms, therapeutic potential, and translational challenges.

Advances in protein chemistry and structural biology·2026

Same author

Phytochemical targeting of SASP2-mediated DNA protection to impair spore resilience in Bacillus cereus: A Computational Investigation.

Molecular diversity·2026

Search research articles

Related Experiment Video

Updated: May 17, 2026

Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People

Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People

Published on: July 5, 2017

Decrease in antioxidant status of plasma and erythrocytes from geriatric population.

Manjulata Kumawat¹, Tarun Kumar Sharma, Ishwar Singh

¹Department of Biochemistry, Pt. B.D. Sharma University of Health Sciences, PGIMS, Rohtak, Haryana, India.

Disease Markers

|October 24, 2012

Summary

Geriatric populations exhibit increased oxidative stress and reduced antioxidant defenses, leading to dyslipidemia and higher cardiovascular disease risk. Early prevention strategies against dyslipidemia are crucial for the elderly.

Related Experiment Videos

Last Updated: May 17, 2026

Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People

Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People

Published on: July 5, 2017

Area of Science:

Biochemistry
Gerontology
Cardiovascular Health

Background:

Aging is linked to increased free radical damage, causing physiological and clinical changes.
Oxidative stress and its impact on health are significant concerns in the elderly population.

Purpose of the Study:

To investigate the status of lipid profiles and antioxidant enzymes in the geriatric population.
To assess malondialdehyde levels as an indicator of lipid peroxidation in the elderly.

Main Methods:

A study involving 150 subjects: 75 healthy young adults (20-30 years) and 75 elderly individuals (50-70 years).
Analysis of lipid profile, reduced glutathione, glutathione peroxidase, glutathione reductase, catalase, superoxide dismutase, and malondialdehyde using standard methods.

Main Results:

Geriatric subjects showed significantly higher levels of total cholesterol, triglycerides, LDL-C, VLDL-C, malondialdehyde, and catalase compared to younger controls.
Elderly individuals exhibited significantly lower levels of HDL-C, reduced glutathione, glutathione peroxidase, glutathione reductase, and superoxide dismutase.

Conclusions:

Enhanced oxidative stress and diminished antioxidant defense mechanisms are evident in the geriatric population, potentially contributing to the aging process.
Dyslipidemia is a major risk factor for cardiovascular diseases in the elderly, with a notable lack of awareness regarding its link to blood lipids.
Implementing early preventive strategies for dyslipidemia is recommended for the geriatric population to mitigate cardiovascular risks.